AbbVie Buy or Sell Recommendation

Macroaxis provides AbbVie Inc buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AbbVie positions. The advice algorithm takes into account all of AbbVie Inc available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from AbbVie buy-and-hold prospective. Check also AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Investment Horizon


Risk Tolerance

Execute Advice
AbbVie Inc -- USA Stock  

USD 93.61  0.86  0.91%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding AbbVie Inc is 'Strong Hold'.
For the selected time horizon AbbVie Inc has a risk adjusted performance of (0.026484), jensen alpha of (0.14), total risk alpha of (0.25), sortino ratio of 0.0 and treynor ratio of 4.15
Macroaxis provides buy, hold, or sell suggestion on AbbVie Inc to complement and cross-verify current analyst consensus on AbbVie Inc. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure AbbVie is not overpriced, please confirm all AbbVie Inc fundamentals including its Shares Outstanding, Net Income, Price to Earnings To Growth, as well as the relationship between Price to Book and Current Ratio . Given that AbbVie Inc has Price to Earning of 23.02 times, we suggest you validate AbbVie Inc market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Returns Distribution Density

Mean Return0.13Value At Risk2.43
Potential Upside2.43Standard Deviation1.46
 Return Density 

AbbVie Greeks

Alpha over DOW
βBeta against DOW=0.03
Overall volatility
 IrInformation ratio =0.11

AbbVie Volatility Alert

AbbVie Inc exhibits very low volatility with skewness of 0.14 and kurtosis of -0.2. However, we advise investors to further study AbbVie Inc technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare AbbVie to competition
FundamentalsAbbViePeer Average
Return On Equity113.57 % (15.17) %
Return On Asset9.48 % (15.64) %
Profit Margin24.77 % (5.5) %
Operating Margin38.11 % (10.91) %
Current Valuation179.56 B152.14 B
Shares Outstanding1.6 B1.43 B
Shares Owned by Insiders0.07 % 6.91 %
Shares Owned by Institutions71.93 % 18.37 %
Number of Shares Shorted30.39 M3.24 M
Price to Earning23.02 times40.69 times
Price to Book24.83 times14.44 times
Price to Sales5.59 times17.81 times
Revenue26.71 B9.85 B
Gross Profit19.8 B21.75 B
EBITDA11.56 B1.41 B
Net Income6.58 B517.71 M
Cash and Equivalents7.21 B3.89 B
Cash per Share4.52 times5.17 times
Total Debt37.54 B7.36 B
Debt to Equity624.7 % 0.72 %
Current Ratio1.38 times3.3 times
Book Value Per Share3.77 times13.64 times
Cash Flow from Operations7.1 B1.25 B
Short Ratio5.37 times2.09 times
Earnings Per Share4.07 times2.3 times
Price to Earnings To Growth1.09 times1.22 times
Number of Employees28 K10.67 K
Market Capitalization149.44 B29.78 B
Total Asset53.05 B126.86 B
Retained Earnings4.38 B38.24 B
Working Capital5.42 B3.58 B
Current Asset16.31 B36.8 B
Strong Hold


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

   Acquisition by Thomas Hurwich of 3100 shares of AbbVie subject to Rule 16b-3 [view details]
Risk Adjusted Performance(0.026484)
Market Risk Adjusted Performance4.16
Mean Deviation1.13
Coefficient Of Variation(1,145)
Standard Deviation1.46
Information Ratio(0.11)
Jensen Alpha(0.14)
Total Risk Alpha(0.25)
Treynor Ratio4.15
Maximum Drawdown4.18
Value At Risk(2.43)
Potential Upside2.43

Current Valuation

AbbVie Current Valuation Analysis
AbbVie Inc is the top company in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Pharmaceuticals And Biosciences industry is presently estimated at about 425.8 Billion. AbbVie totals roughly 179.56 Billion in current valuation claiming about 42% of equities listed under Pharmaceuticals And Biosciences industry.